Pediatrics & Neonatology
Volume 51, Issue 3 , Pages 143-148 , June 2010

Understanding Neonatal Jaundice: A Perspective on Causation

Received 19 November 2009 ,Revised 23 December 2009 ,Accepted 15 January 2010.

References 

  1. Tenhunen R , Marver HS , Schmid R . The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase . Proc Natl Acad Sci USA . 1968;61:748–755
  2. Maines MD . Heme Oxygenase: Clinical Applications and Functions . Boca Raton: CRC Press; 1992;
  3. McCoubrey WK , Huang TJ , Maines MD . Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3 . Eur J Biochem . 1997;247:725–732
  4. Stevenson DK . American Pediatric Society Presidential Address 2006: science on the edge with life in the balance . Pediatr Res . 2006;60:630–635
  5. Ostrander CR , Cohen RS , Hopper AO , Cowan BE , Stevens GB , Stevenson DK . Paired determinations of blood carboxyhemoglobin concentration and carbon monoxide excretion rate in term and preterm infants . J Lab Clin Med . 1982;100:745–755
  6. Vreman HJ , Wong RJ , Harmatz P , Fanaroff AA , Berman B , Stevenson DK . Validation of the Natus CO-Stat™ End Tidal Breath Analyzer in children and adults . J Clin Monit Comput . 1999;15:421–427
  7. Stevenson DK , Vreman HJ . Carbon monoxide and bilirubin production in neonates . Pediatrics . 1997;100:252–254
  8. Stevenson DK , Dennery PA , Hintz SR . Understanding newborn jaundice . J Perinatol . 2001;21:S21–S24
  9. Kaplan M , Muraca M , Hammerman C , et al.   Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice . Pediatrics . 2002;110:e47
  10. AAP  . Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation . Pediatrics . 2004;114:297–316
  11. Stocker R , Yamamoto Y , McDonagh AF , Glazer AN , Ames BN . Bilirubin is an antioxidant of possible physiological importance . Science . 1987;235:1043–1046
  12. Morita T , Perrella MA , Lee ME , Kourembanas S . Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP . Proc Natl Acad Sci USA . 1995;92:1475–1479
  13. Acevedo CH , Ahmed A . Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy . J Clin Invest . 1998;101:949–955
  14. Otterbein LE , Soares MP , Yamashita K , Bach FH . Heme oxygenase-1: unleashing the protective properties of heme . Trends Immunol . 2003;24:449–455
  15. Brune B , Ullrich V . Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase . Mol Pharmacol . 1987;32:497–504
  16. Chung HT , Choi BM , Kwon YG , Kim YM . Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation . Methods Enzymol . 2008;441:329–338
  17. Ryter SW , Choi AM . Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models . Novartis Found Symp . 2007;280:165–175 discussion 175–81
  18. Ryter SW , Otterbein LE , Morse D , Choi AM . Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance . Mol Cell Biochem . 2002;234–235:249–263
  19. Leinders-Zufall T , Shepherd GM , Zufall F . Regulation of cyclic nucleotide-gated channels and membrane excitability in olfactory receptor cells by carbon monoxide . J Neurophysiol . 1995;74:1498–1508
  20. Prabhakar NR , Dinerman JL , Agani FH , Snyder SH . Carbon monoxide: a role in carotid body chemoreception . Proc Natl Acad Sci USA . 1995;92:1994–1997
  21. Vreman HJ , Gillman MJ , Downum KR , Stevenson DK . In vitro generation of carbon monoxide from organic molecules and synthetic metalloporphyrins mediated by light . Dev Pharmacol Ther . 1990;15:112–124
  22. Vreman HJ , Knauer Y , Wong RJ , Chan ML , Stevenson DK . Dermal carbon monoxide excretion in neonatal rats during light exposure . Pediatr Res . 2009;66:66–69
  23. Vreman HJ , Wong RJ , Sanesi CA , Dennery PA , Stevenson DK . Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system . Can J Physiol Pharmacol . 1998;76:1057–1065
  24. Vreman HJ , Wong RJ , Stevenson DK . Carbon monoxide in breath, blood, and other tissues . In:  Penney DG editors. Carbon Monoxide Toxicity . Boca Raton: CRC Press; 2000;p. 19–60
  25. Stevenson DK , Vreman HJ , Oh W , et al.   Bilirubin production in healthy term infants as measured by carbon monoxide in breath . Clin Chem . 1994;40:1934–1939
  26. Vreman HJ , Baxter LM , Stone RT , Stevenson DK . Evaluation of a fully automated end-tidal carbon monoxide instrument for breath analysis . Clin Chem . 1996;42:50–56
  27. Vreman HJ , Stevenson DK , Oh W , et al.   Semiportable electrochemical instrument for determining carbon monoxide in breath . Clin Chem . 1994;40:1927–1933
  28. Stevenson DK , Fanaroff AA , Maisels MJ , et al.   Prediction of hyperbilirubinemia in near-term and term infants . Pediatrics . 2001;108:31–39
  29. Bhutani VK , Johnson L , Sivieri EM . Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns . Pediatrics . 1999;103:6–14
  30. Stevenson DK , Wong RJ , DeSandre GH , Vreman HJ . A primer on neonatal jaundice . Adv Pediatr . 2004;51:263–288
  31. Stevenson DK , Wong RJ , Hintz SR , Vreman HJ . The jaundiced newborn. Understanding and managing transitional hyperbilirubinemia . Minerva Pediatr . 2002;54:373–382
  32. Maines MD . Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat . Biochim Biophys Acta . 1981;673:339–350
  33. Stevenson DK , Rodgers PA , Vreman HJ . The use of metalloporphyrins for the chemoprevention of neonatal jaundice . Am J Dis Child . 1989;143:353–356
  34. Vreman HJ , Wong RJ , Stevenson DK . Alternative metalloporphyrins for the treatment of neonatal jaundice . J Perinatol . 2001;21:S108–S113 discussion S125–7
  35. Wong RJ , Bhutani VK , Vreman HJ , Stevenson DK . Tin mesoporphyrin for the prevention of severe neonatal hyperbilirubinemia . Neoreviews . 2007;8:e77–e84
  36. Vreman HJ , Lee OK , Stevenson DK . In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG . Am J Med Sci . 1991;302:335–341
  37. Appleton SD , Chretien ML , McLaughlin BE , et al.   Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations . Drug Metab Dispos . 1999;27:1214–1219
  38. Abate A , Zhao H , Wong RJ , Stevenson DK . The role of Bach1 in the induction of heme oxygenase by tin mesoporphyrin . Biochem Biophys Res Commun . 2007;354:757–763
  39. Hajdena-Dawson M , Zhang W , Contag PR , et al.   Effects of metalloporphyrins on heme oxygenase-1 transcription: correlative cell culture assays guide in vivo imaging . Mol Imaging . 2003;2:138–149
  40. Morioka I , Wong RJ , Abate A , Vreman HJ , Contag CH , Stevenson DK . Systemic effects of orally-administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice . Pediatr Res . 2006;59:667–672
  41. Morisawa T , Wong RJ , Bhutani VK , Vreman HJ , Stevenson DK . Inhibition of heme oxygenase activity in newborn mice by azalanstat . Can J Physiol Pharmacol . 2008;86:651–659
  42. Zhang W , Contag PR , Hardy J , et al.   Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1 . J Mol Med . 2002;80:655–664
  43. Zhang W , Feng JQ , Harris SE , Contag PR , Stevenson DK , Contag CH . Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression . Transgenic Res . 2001;10:423–434
  44. Morisawa T , Wong RJ , Xiao H , Bhutani VK , Vreman HJ , Stevenson DK . Inhibition of heme oxygenase activity by chromium mesoporphyrin in the heme-loaded newborn mouse . E-PAS2008 . 2008;6130.9
  45. Kaplan M , Hammerman C , Vreman HJ , Wong RJ , Stevenson DK . Severe hemolysis with normal blood count in a glucose-6-phosphate dehydrogenase deficient neonate . J Perinatol . 2008;28:306–309
  46. Kaplan M , Hammerman C , Renbaum P , Levy-Lahad E , Vreman HJ , Stevenson DK . Differing pathogenesis of perinatal bilirubinemia in glucose-6-phosphate dehydrogenase-deficient versus-normal neonates . Pediatr Res . 2001;50:532–537
  47. Kaplan M , Renbaum P , Vreman HJ , et al.   (TA)n UGT 1A1 promoter polymorphism: a crucial factor in the pathophysiology of jaundice in G-6-PD deficient neonates . Pediatr Res . 2007;61:727–731
  48. Kaplan M , Hammerman C , Rubaltelli FF , et al.   Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism . Hepatology . 2002;35:905–911
  49. Kaplan M , Renbaum P , Levy-Lahad E , Hammerman C , Lahad A , Beutler E . Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia . Proc Natl Acad Sci USA . 1997;94:12128–12132
  50. Berardi A , Lugli L , Ferrari F , et al.   Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism . Biol Neonate . 2006;90:243–246
  51. Watchko JF . Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns . Neuromolecular Med . 2006;8:513–530
  52. Lin Z , Fontaine J , Watchko JF . Coexpression of gene polymorphisms involved in bilirubin production and metabolism . Pediatrics . 2008;122:e156–e162

PII: S1875-9572(10)60027-7

doi: 10.1016/S1875-9572(10)60027-7

Pediatrics & Neonatology
Volume 51, Issue 3 , Pages 143-148 , June 2010

Article Tools